Latest Breaking News On - White research institute - Page 1 : comparemela.com

Leading US Cardiologist Visits Heart Research Institute

Leading US Cardiologist Visits Heart Research Institute
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesJaved butlerBen freedmanCarmine gentileMary kavurmaBaylor scottChris stanleyAshish misraHeart research instituteWhite research instituteProfessor of medicine at university mississippiRenal advisory panelProf javedAssoc prof mary kavurmaProf ben freedmanProf andrew

ACC: Empagliflozin Does Not Cut Risk for Heart Failure After Acute MI

No reduction in risk for first hospitalization for heart failure or death seen among patients at increased risk for heart failure

United statesEli lillyJaved butlerBaylor scottAmerican college of cardiologyBoehringer ingelheimWhite research instituteHealthday newsNew england journalAmerican college

Empagliflozin Does Not Cut Risk for Heart Failure After Acute MI

No reduction in risk for first hospitalization for heart failure or death seen among patients at increased risk for heart failure

United statesBaylor scottEli lillyJaved butlerWhite research instituteBoehringer ingelheimAmerican college of cardiologyHealthday newsNew england journalAmerican college

Tenax Therapeutics to Host KOL Event: LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study

Tenax Therapeutics to Host KOL Event: LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Columbia universityNew yorkUnited statesJohns hopkins hospitalAmerican college of cardiologyCity of new yorkMayo clinic in rochesterHarvard universitySanjiv shahPatrickh lehanJaved butlerDaniel burkhoffCharlesa garganoJohn frauncesmanaging directorlifesciBaylor scott white research instituteInternational society for heart

Study: Empagliflozin shows mixed results in heart attack patients

Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did not show a significant benefit in reducing overall heart failure hospitalizations or death from any cause, according to a study presented at the American College of Cardiology's Annual Scientific Session.

United statesUniversity of mississippiJaved butlerEli lillyBaylor scottAmerican college of cardiologyWhite research instituteBoehringer ingelheimAmerican college of cardiology annual scientific sessionAmerican collegeAnnual scientificNew england journal